Castle Biosciences, Inc.is a molecular diagnostics company offering innovative test solutions to aid clinicians in the diagnosis and treatment of dermatologic cancers, barrett’s esophagus, uveal melanoma, and in the treatment of mental health conditions. The firm offers DecisionDx-Melanoma, a proprietary multi-gene expression profile (GEP) test that predicts the risk of metastasis and recurrence for patients diagnosed with invasive cutaneous melanoma. It also markets DecisionDx-UM, Decision Dx DiffDx-Melanoma, DecisonDx-CMSeq, DecisionDx-SCC, DecsionDx-UMSeq, and DecisonDX-PRAME. The company was founded by Derek J. Maetzold in September 2007 and is headquartered in Friendswood, TX.
Sector:
Health Technology
Industry:
Medical Specialties
Employees:
761
Frequently Asked Questions
What is Market Cap of Castle Biosciences Inc?
Market cap, also known as market capitalization, is the total market value of a company. It’s calculated by multiplying the current market price by the total number of shares outstanding. Castle Biosciences Inc market cap is $665.45M.
What is the 52-week high for Castle Biosciences Inc?
52 week high is the highest price of a stock in the past 52 weeks, or one year. Castle Biosciences Inc 52 week high is $35.84 as of September 12, 2025.
What is the 52-week low for Castle Biosciences Inc?
52 week low is the lowest price of a stock in the past 52 weeks, or one year. Castle Biosciences Inc 52 week low is $14.59 as of September 12, 2025.
What is Castle Biosciences Inc stock price today?
Castle Biosciences Inc stock price today is $22.75.
What was Castle Biosciences Inc stock price yesterday?
Castle Biosciences Inc stock price yesterday was $22.94.
What is the PE ratio of Castle Biosciences Inc?
The Price-to-Earnings (or P/E) ratio is a commonly used tool for valuing a company. It’s calculated by dividing the current share price by the earnings per share (or EPS). It can also be calculated by dividing the company’s Market Cap by the Net Profit. Castle Biosciences Inc’s P/E ratio is -64.49.
What is the Price-to-Book ratio of Castle Biosciences Inc?
The Price-to-Book (P/B) ratio is a commonly used tool for valuing a company. It’s calculated by dividing a company’s market capitalization by its book value. Castle Biosciences Inc P/B ratio is 1.4600.
What is the 50-day moving average of Castle Biosciences Inc?
The 50-day moving average is a frequently used data point by active investors and traders to understand the trend of a stock. It’s calculated by averaging the closing stock price over the previous 50 trading days. Castle Biosciences Inc 50-day moving average is $19.64.
How many employess does Castle Biosciences Inc has?